Bone mass in infants assessed by dual-energy X-ray absorptiometry in Thailand

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20260507011

Enrollment

Registered

2026-05-07

Start date

2026-05-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypovitaminosis D in preterm infants and full term infant in Thailand Dual-Energy X-Ray Absorptiometry Low Bone Mineral Density Metabolic Bone Diseases Newborn Photon Absorptiometry Premature Infant Vitamin D Deficiency

Interventions

To investigate the reference values of body composition obtained by dual energy X ray absorptiometry and body impedance analysis in growing preterm infants (36-40 weeks postmenstrual age to 6-12 mont

Screening

Preterm and infant in Thailand

Eligibility

Sex/Gender

All

Age

1 Days to 12 Months

Inclusion criteria

Inclusion criteria: 1. Stable preterm neonates (BW less than 1800 g) who admitted to neonatal intensive care unit or step down ward, and ready to discharge (physiologic stability as well as sufficient weight gain, adequate maintenance of normal body temperature fully clothed in an open bed with normal ambient temperature neither radiant warmer nor incubator at least 3-5 days) 2. Preterm and full-term infants who were followed up in OPD with routine blood sampling (e.g. complete blood count for anemic screening) 6-12 months of PNA

Exclusion criteria

Exclusion criteria: 1. Congenital infections 2. Malformations, syndromes, or genetic defects 3. Sick infants during DXA procedure 4. Cardiopulmonary instability 5. Oxygen supplement 6. History of major surgery (e.g., neurosurgery, cardiovascular surgery, gastrointestinal surgery) 7. Neonates need long term medication (more than 1 month), except minerals and vitamins. 8. Parents decision not to participate in the study 9. Birth weight (at birth) or body weight (at 6-12 months) below the 3-95 percentile of gestational age or corrected age, respectively. 10. Congenital or postnatal bone fracture 11. Neonates who have never undergone a DEXA procedure.

Design outcomes

Primary

Measure	Time frame
Bone mass 1 time at appointment date dual energy X ray absorptiometry	—

Secondary

Measure	Time frame
Bone mass 1 time at appointment date Body impedance analysis ,Vitamin D 1 time at appointment date The LIAISON 25 OH Vitamin D TOTAL Assay uses chemiluminescent immunoassay (CLIA) technology	—

Countries

Thailand

Contacts

Public ContactAnucha Thatrimontrichai

Prince of Songkla University

tanucha@medicine.psu.ac.th074451257

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026